🔗 Share this article

Chancellor Reeves has revealed she is planning "specific measures to address cost of living issues" in the forthcoming Budget.

During an interview with media outlets, she emphasized that curbing price rises is a collective task of both the administration and the central bank.

The United Kingdom's price growth is projected to be the highest among the Group of Seven advanced economies this calendar year and the following year.

Potential Utility Bill Interventions

It is understood the government could take action to lower utility costs, for instance by cutting the current 5% level of value-added tax applied on energy.

An additional option is to reduce some of the policy costs presently added to bills.

Fiscal Limitations and Analyst Predictions

The administration will receive the latest draft from the independent fiscal watchdog, the Office for Budget Responsibility, on the start of the week, which will reveal how much scope there is for these actions.

The expectation from most analysts is that Reeves will have to declare higher taxes or spending cuts in order to adhere to her declared borrowing rules.

Previously on the same day, calculations suggested there was a twenty-two billion pound gap for the Treasury chief to address, which is at the lower end of projections.

"There's a shared task between the Bank of England and the government to continue tackling some of the causes of price increases," the Chancellor told the BBC in the US capital, at the yearly gatherings of the International Monetary Fund and global financial institution.

Revenue Pledges and Global Issues

While a great deal of the attention has been on probable tax increases, the chancellor said the most recent data from the fiscal watchdog had not changed her vow to manifesto promises not to increase rates on income tax, sales tax or social security contributions.

She blamed an "uncertain global environment" with growing geopolitical and trade tensions for the fiscal tax moves, likely to be targeted on those "wealthiest."

International Economic Tensions

Addressing worries about the United Kingdom's economic relations with China she said: "The UK's national security invariably are paramount."

Recent announcement by China to strengthen trade restrictions on critical minerals and other resources that are essential for advanced tech production led American leader the US President to suggest an further 100% tariff on imports from the Asian country, raising the possibility of an all-out commercial conflict between the two economic giants.

The American finance chief described the Chinese move "commercial pressure" and "a international production power grab."

Inquired about considering the American proposal to join its battle with the Asian nation, Reeves said she was "very concerned" by Chinese actions and called on the Chinese government "to avoid restrictions and limit trade."

She said the action was "damaging for the world economy and generates further obstacles."

"I believe there are areas where we should challenge Chinese policies, but there are also valuable opportunities to trade with China's economy, including financial services and other areas of the economy. We've got to maintain that balance correct."

The chancellor also affirmed she was working with G7 counterparts "on our own critical minerals plan, so that we are less reliant."

Health Service Drug Costs and Funding

Reeves also recognized that the cost the National Health Service spends on drugs could increase as a result of current discussions with the Trump administration and its pharmaceutical firms, in exchange for reduced taxes and funding.

Some of the biggest global drug companies have said in recent statements that they are either halting or canceling projects in the United Kingdom, with some blaming the modest returns they are obtaining.

Last month, the government science advisor said the cost the health service pays for drugs would need to rise to prevent firms and pharmaceutical investment leaving the United Kingdom.

Reeves stated to the BBC: "We have seen due to the payment system, that clinical trials, new drugs have not been provided in the UK in the manner that they are in other continental states."

"Our aim is to make sure that people receiving care from the National Health Service are able to receive the finest life-saving drugs in the globe. And so we are looking at these issues, and... seeking to obtain additional capital into the UK."